Skip to main content
. Author manuscript; available in PMC: 2017 Feb 16.
Published in final edited form as: Int J Obes (Lond). 2016 May 2;40(9):1353–1359. doi: 10.1038/ijo.2016.81

Table 3.

Odds of Future Disease Using Insulin and Adiponectin, with and without MetS z-score.

Incident Disease by PHU Visit:

Incident Diabetes (n = 22) Incident CVD (n = 19)

Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
Model 1
 Ln(Insulin) at PFS 8.40 (3.76, 18.73) < 0.001 3.44 (1.66, 7.12) < 0.001
ROC AUC 0.85 0.75
Model 2
 Ln(Adinoponectin) at PFS 0.25 (0.11, 0.53) < 0.001 0.68 (0.32, 1.44) 0.318
ROC AUC 0.72 0.57
Model 3
 Mets Z-score at PFS 5.60 (2.98, 10.56) < 0.001 3.51 (2.08, 5.93) < 0.001
ROC AUC 0.87 0.82
Model 4
 Ln(Insulin) at PFS 3.42 (1.31, 8.92) 0.012 1.14 (0.43, 3.03) 0.786
 Mets Z-score at PFS 3.45 (1.63, 7.30) 0.001 3.35 (1.79, 6.26) < 0.001
ROC AUC 0.89 0.82
Model 5
 Ln(Adinoponectin) at PFS 0.47 (0.18, 1.24) 0.128 2.37 (0.86, 6.57) 0.097
 Mets Z-score at PFS 5.00 (2.56, 9.77) < 0.001 4.39 (2.41, 8.00) < 0.001
ROC AUC 0.87 0.82
Model 6
 Ln(Insulin) at PFS 3.04 (1.14, 8.13) 0.027 1.39 (0.49, 3.93) 0.539
 Ln(Adinoponectin) at PFS 0.63 (0.23, 1.71) 0.362 2.52 (0.90, 7.06) 0.080
 MetS Z-score at PFS 3.35 (1.56, 7.18) 0.002 3.97 (2.02, 7.79) < 0.001
ROC AUC 0.89 0.82